(Thanks to Atid-EDI) Israel’s BioLineRX announced that its BL-8040 treatment for Chronic Myeloid Leukemia (CML) stopped growth of cancer cells in-vitro and caused them to self-destruct. It also reversed any protection given to the CML cancer cells from a bone marrow transplant.
http://www.biolinerx.com/default.asp?pageid=16&itemid=259
Positive results in Leukemia trials
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.